Target intelligence / Profile preview

Colonocyte energy metabolism via short-chain fatty acid production

Molecular classification
Metabolic pathway, Biological process
01

Overview

Colonocyte energy metabolism via short-chain fatty acid (SCFA) production describes the physiological process where colonic epithelial cells derive approximately 60-70% of their energy from the oxidation of fermentation products. Unlike most tissues that prefer glucose, colonocytes utilize butyrate, acetate, and propionate—produced by gut microbiota from dietary fibers—as their primary fuel source (Roediger, 1980; Hamer et al., 2008). This metabolic pathway is essential for maintaining the intestinal mucosal barrier and overall gut health. In diseases like ulcerative colitis, a 'metabolic starvation' occurs where colonocytes fail to effectively oxidize SCFAs, leading to mucosal inflammation and injury (Thibault et al., 2010). Furthermore, SCFAs function as signaling molecules by activating specific G protein-coupled receptors (GPR41, GPR43, GPR109A) and inhibiting histone deacetylases, thereby influencing immune responses and suppressing oncogenesis in colorectal cancer (Ganapathy et al., 2013; Tan et al., 2014). Therapeutic strategies targeting this process include the use of prebiotics, probiotics, and direct SCFA supplementation to restore metabolic homeostasis and reduce inflammation.

Other names
Butyrate metabolismColonic SCFA oxidationColonocyte energy homeostasisMicrobial fermentation energy utilization
02

Mechanism of action

Short-chain fatty acids (SCFAs) serve as the primary respiratory fuel for colonocytes, undergoing mitochondrial beta-oxidation to generate ATP; they also act as ligands for G protein-coupled receptors (FFAR2, FFAR3, HCAR2) and inhibit histone deacetylases (HDACs) to modulate gene expression and inflammatory signaling.

03

Biological functions

Energy metabolismATP productionCellular homeostasisEpigenetic regulationImmune modulationMucosal barrier maintenance
04

Disease associations

Inflammatory bowel diseaseUlcerative colitisColorectal cancerCrohn's diseaseObesityType 2 diabetes
05

Safety considerations

Gastrointestinal distress (bloating, flatulence)The 'butyrate paradox' (differential effects on healthy vs. cancerous cells)Potential for metabolic acidosis with high-dose systemic administrationAlteration of gut microbiota composition
06

Interacting drugs

Sodium butyrate

5 more in the full profile.

07

Biomarkers

Fecal short-chain fatty acid concentrationMCT1 (SLC16A1) expression levelsGPR43 (FFAR2) expression levelsButyryl-CoA dehydrogenase activity

Beyond the preview

Go deeper on Colonocyte energy metabolism via short-chain fatty acid production.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Colonocyte energy metabolism via short-chain fatty acid production.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call